Specifically, function enrichment analysis indicated that these abnormal genes were predominantly concentrated in the Wnt‐beta Catenin signalling pathway, known to be activated in pituitary tumour.56, 57. This evidence concerns the gene CTNNB1 and pituitary tumor.